ImportRefusal LogoImportRefusal

Glaxosmith-Kline

⚠️ Moderate Risk

FEI: 3004410504 • Research Triangle Park, NC • UNITED STATES

FEI

FEI Number

3004410504

📍

Location

Research Triangle Park, NC

🇺🇸
🏢

Address

Unknown Street, , Research Triangle Park, NC, United States

Moderate Risk

FDA Import Risk Assessment

34.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
7/5/2013
Latest Refusal
11/20/2012
Earliest Refusal

Score Breakdown

Violation Severity
62.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1792×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
7/5/2013
63BCQ25FLUTICASONE PROPIONATE (BRONCHODILATOR)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/4/2013
62VIY32LAMIVUDINE (ANTI-VIRAL)
179AGR RX
Florida District Office (FLA-DO)
11/20/2012
66VAA99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
Florida District Office (FLA-DO)

Frequently Asked Questions

What is Glaxosmith-Kline's FDA import refusal history?

Glaxosmith-Kline (FEI: 3004410504) has 3 FDA import refusal record(s) in our database, spanning from 11/20/2012 to 7/5/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxosmith-Kline's FEI number is 3004410504.

What types of violations has Glaxosmith-Kline received?

Glaxosmith-Kline has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxosmith-Kline come from?

All FDA import refusal data for Glaxosmith-Kline is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.